207 related articles for article (PubMed ID: 10471318)
1. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
Mirski SE; Gerlach JH; Cole SP
Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
[TBL] [Abstract][Full Text] [Related]
2. The cytochrome b5 tail anchors and stabilizes subdomains of human DNA topoisomerase II alpha in the cytoplasm of retrovirally infected mammalian cells.
Soltermann A; Ernst A; Leroy D; Stahel RA; Gasser SM
Exp Cell Res; 1999 Jun; 249(2):308-19. PubMed ID: 10366430
[TBL] [Abstract][Full Text] [Related]
3. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
4. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
Mo YY; Beck WT
Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
[TBL] [Abstract][Full Text] [Related]
5. Homologous and heterologous protein-protein interactions of human DNA topoisomerase IIalpha.
Kroll DJ
Arch Biochem Biophys; 1997 Sep; 345(2):175-84. PubMed ID: 9308887
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells.
Mirski SE; Sparks KE; Friedrich B; Köhler M; Mo YY; Beck WT; Cole SP
Exp Cell Res; 2007 Feb; 313(3):627-37. PubMed ID: 17182034
[TBL] [Abstract][Full Text] [Related]
7. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
[TBL] [Abstract][Full Text] [Related]
8. Identification of a single nuclear localization signal in the C-terminal domain of an Aspergillus DNA topoisomerase II.
Kim KH; Kanbe T; Akashi T; Mizuguchi I; Kikuchi A
Mol Genet Genomics; 2002 Nov; 268(3):287-97. PubMed ID: 12436251
[TBL] [Abstract][Full Text] [Related]
9. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.
Herzog CE; Holmes KA; Tuschong LM; Ganapathi R; Zwelling LA
Cancer Res; 1998 Dec; 58(23):5298-300. PubMed ID: 9850052
[TBL] [Abstract][Full Text] [Related]
10. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
11. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
Sakaguchi A; Akashi T; Kikuchi A
Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
Chen M; Beck WT
Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
[TBL] [Abstract][Full Text] [Related]
13. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.
Christensen MO; Larsen MK; Barthelmes HU; Hock R; Andersen CL; Kjeldsen E; Knudsen BR; Westergaard O; Boege F; Mielke C
J Cell Biol; 2002 Apr; 157(1):31-44. PubMed ID: 11927602
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
16. Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha.
Mirski SE; Gerlach JH; Cummings HJ; Zirngibl R; Greer PA; Cole SP
Exp Cell Res; 1997 Dec; 237(2):452-5. PubMed ID: 9434641
[TBL] [Abstract][Full Text] [Related]
17. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents.
Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA
Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041
[TBL] [Abstract][Full Text] [Related]
18. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG
Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864
[TBL] [Abstract][Full Text] [Related]
20. Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals.
Turner JG; Engel R; Derderian JA; Jove R; Sullivan DM
J Cell Sci; 2004 Jun; 117(Pt 14):3061-71. PubMed ID: 15173319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]